RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Citing a Change in Thinking, FDA Withdraws Lupus Product Guidance

    The US Food and Drug Administration (FDA) said it is withdrawing a guidance document published in June 2010 in light of the document no longer reflecting its current thinking on the topic. In its 26 June 2012 Federal Register posting, FDA said its guidance, " Lupus Nephritis Caused by Systemic Lupus Erythematosus-Developing Medical Products for Treatment ," was being withdrawn immediately. Systemic Lupus Erythamatosus is an autoimmune disease in which the body's immun...